Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucia Sofrankova has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Albert Breier

    Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 841 04 Bratislava, Slovakia

    3 shared publications
  • Branislav Pavilek

    Institute of Organic Chemistry, Catalysis, and Petrochemistry, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, SK-812 37 Bratislava, Slovakia

    2 shared publications
  • Jana Spaldova

    Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology , Slovak University of Technology in Bratislava , Radlinskeho 9, SK-81237 , Bratislava , Slovak Republic

    2 shared publications
  • Mária Balážová

    Department of Membrane Biochemistry, Institute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, 84104 Bratislava, Slovakia

    2 shared publications
  • Zdena Sulova

    Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 841 04 Bratislava, Slovakia

    2 shared publications
  • Aleš Kvasnička

    Department of Medical Biochemistry, Oslo University Hospital, 4950 Oslo, Norway

    1 shared publication

Latest Publications

  • Open Access

    Long-Term Static Cultivation Alters Lipid Metabolism and Bioenergetic Capacity in A549 Cells

    by Ivana Ďurišová, Lucia Šofranková, Aleš Kvasnička, Miroslav Baláž, Ivana Fábryová, David Friedecký, Mária Balážová

    A549 cells are widely used as an in vitro model of alveolar type II (ATII) epithelial cells; however, their phenotype and metabolic state are highly sensitive to culture conditions, cell density, and the duration of static, non-passaged cultivation. Here, we examined how prolonged static culture affects lipid metabolism, mitochondrial bioenergetics, and viability in A549 cells. A549 cultures were maintained without passaging for up to 25 days in DMEM or Ham’s F-12 and analyzed using lipid secretion assays, targeted lipidomics, [14C]-acetate incorporation, Seahorse bioenergetic profiling, and transcriptional analysis of stress-associated markers. Several surfactant-associated readouts were highest during early culture, peaking on day 7, as evidenced by elevated expression of ABCA3 and SP-A and maximal secretion of surfactant-associated phospholipids. With prolonged cultivation and increasing culture density, cellular phosphatidylglycerol levels declined progressively and became nearly undetectable by day 25, accompanied by reduced anabolic lipid metabolism, lower oxygen consumption, and impaired glycolytic activity. These changes coincided with increased reactive oxygen species, elevated intracellular Ca2+ levels, and increased expression of stress-associated transcripts, including CASP1, IL1B, and C3. Later stages were also associated with reduced mitochondrial respiration and decreased viability. Collectively, our findings show that prolonged static culture is associated with metabolic remodeling and reduced bioenergetic capacity in A549 cells.


  • Open Access

    Cellular effects of adamantane derivatives in P-glycoprotein leukemia cells

    by Natalia Dostalkova, Lucia Sofrankova, Jana Spaldova, Branislav Pavilek, Ester Pisarova, Lakatos Boris

    Acute myeloid leukemia is a severe hematologic malignancy that predominantly affects older adults and is characterized by high biological variability. One of the main challenges in its treatment is the development of multidrug resistance, often mediated by the overexpression of P-glycoprotein (ABCB1). This transport protein actively expels cytotoxic drugs from cells, reducing the effectiveness of chemotherapy and worsening patient prognosis. Although several generations of P-glycoprotein inhibitors have been developed, their clinical use is significantly limited due to their negative side effects. In recent years, attention has shifted toward natural substances and well-known drugs with broad applications. A promising candidate is amantadine, a lipophilic compound with a stable structure, originally used to treat influenza and Parkinson’s disease. This study focuses on investigating the potential of its derivatives in combating multidrug resistance in acute myeloid leukemia. The results demonstrate that the newly synthesized adamantane derivatives, particularly E-A2, exhibit significant cytotoxic activity in acute myeloid leukemia cell lines, including P-glycoprotein-expressing resistant variants. Importantly, E-A2 was able to induce both apoptotic and necrotic cell death and maintained its activity in multidrug resistant models.

  • Open Access

    P-glycoprotein-independent cytotoxic effects of 5-aminopyrazole in L1210 leukemia cells

    by Lucia Sofrankova, Jana Spaldova, Pavol Stefik, Branislav Pavilek, Dusan Bortnak, Lucia Pavlikova, Ivana Zidekova, Daniel Vegh, Viktor Milata, Albert Breier, et al.


  • The subtherapeutic dose of valproic acid induces the activity of cardiolipin-dependent proteins

    by Paulina Horonyova, Ivana Durisova, Petra Cermakova, Lenka Babelova, Barbora Buckova, Lucia Sofrankova, Martin Valachovic, Yuan-Hao Howard Hsu, Maria Balazova


  • Open Access

    Zosuquidar: An Effective Molecule for Intracellular Ca2+ Measurement in P-gp Positive Cells

    by Livia Pelegrinova, Lucia Sofrankova, Jana Spaldova, Pavol Stefik, Zdena Sulova, Albert Breier, Katarina Elefantova

    Intracellular calcium, as a second messenger, is involved in multilevel cellular regulatory pathways and plays a role (among other processes) in switching between survival and initiation of cell death in neoplastic cells. The development of multidrug resistance (MDR) in neoplastic cells is associated with the ability of cells to escape programmed cell death, in which dysregulation of intracellular calcium may play an important role. Therefore, reliable monitoring of intracellular calcium levels is necessary. However, such a role might be limited by a real obstacle since several fluorescent intracellular calcium indicators are substrates of membrane ABC drug transporters. For example, Fluo-3/AM is a substrate of P-glycoprotein (ABCB1 member of the ABC family), whose overexpression is the most frequent cause of MDR. The overexpression of ABCB1 prevents MDR cell variants from retaining this tracer in the intracellular space where it is supposed to detect calcium. The solution is to use a proper inhibitor of P-gp efflux activity to ensure the retention of the tracer inside the cells. The present study showed that Zosuquidar and Tariquidar (P-gp inhibitors) are suitable for monitoring intracellular calcium, either by flow cytometry or confocal microscopy, in cells overexpressing P-gp.


  • Synthesis of Pyrazoloazepines from 5‐Aminopyrazoles and Study of Their Cytotoxicity in Cancer Treatment

    by Branislav Pavilek, Dušan Bortňák, Jakub Šofranko, Lucia Šofranková, Jana Špaldová, Katarína Elefantová, Petra Olejníková, Ivana Žídeková, Daniel Végh, Svetlana Dokupilová, et al.

    The novel synthetic approach was employed to synthesize a series of 1,8‐dihydropyrazolo[3,4‐b]azepine derivatives from 5‐aminopyrazoles in three‐step synthesis. The structures of the individual derivatives were unambiguously confirmed by spectral methods, including heteronuclear 1H−13C HMBC spectra and other necessary 2D NMR experiments. The obtained pyrazoloazepines and starting aminopyrazoles were subsequently investigated for their potential cytotoxic effect using mouse and human leukemia cell models. The original L1210 (mouse lymphoblastic), MOLM‐13, and SKM‐1 (both human myeloblastic) cell lines and their P‐glycoprotein (P‐gp) expressing cell variants were used. Aminopyrazole 8 was the most effective on murine leukemic lymphoblasts (L1210), while it had a greater effect on P‐gp expressing cells. In contrast, on human leukemic myeloblasts (MOLM‐13, SKM‐1), Aminopyrazoles 10 showed the most pronounced effect, but this was independent of the presence of P‐gp in the cells.